Rush Pharmacy
“Prescriptions are filled by licensed U.S. partner pharmacies, including Rush Pharmacy and Strive Pharmacy, that meet federal and state requirements.”
Kin Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: oral orforglipron alongside the injectables
6.9
★★★☆☆6.9/10
Kin Meds falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $199 a month; its compounded tirzepatide, at $249, is 7% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$199/mo
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
See plans →See plans at Kin Meds →
Compare top-rated alternatives ↓Prices checked October 2026
Kin Meds sells compounded semaglutide from $199 and compounded tirzepatide from $249, covering shipping, supplies and the visit, and nothing renews on its own. It also prescribes Wegovy, Zepbound and Foundayo for a $149/mo consultation fee, with the medication billed on top by NovoCare or LillyDirect. The same account covers TRT, hormones, NAD+, sermorelin, skin and sexual health.
By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $199/moPrice shown up frontPharmacy named
Is Kin Meds legit?
Kin Meds is a real, operating US company, and the FDA has issued it a warning letter. The letter is summarized at the top of this review. Read what it alleges before you decide, and raise it with the clinician who would prescribe for you. We rate Kin Meds 6.9/10 overall.
Is there a Kin Meds promo or coupon code?
We know of no promo or coupon code for Kin Meds. Its listed price is $199 a month. Coupon sites advertising "Kin Meds discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Kin Meds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Kin Meds
9.1/ 10
Verified partnerCollective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
★★★★★9.1/10
Editorial score · methodology
$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →9.3/ 10
Verified partnerEmbody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
★★★★★9.3/10
Editorial score · methodology
$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →7.9/ 10
Verified partnerLuvo Health
Best for: moving between compounded and brand without changing seller
★★★★☆7.9/10
Editorial score · methodology
$179/mo
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Luvo Health review →Kin Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Zepbound
- Starting price
- $199/mo
- FDA status
- 1 FDA warning letter (details below)
How Kin Meds scores
Six columns, each one computed from something Kin Meds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.6/10$249/month is 7% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses orforglipron, semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.0/10The FDA has issued it a warning letter. It names the pharmacy that fills its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Kin Meds
Last checked October 2026- Checked the listed price across 5 dose or plan tiers
- Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
- Checked FDA warning letters for Kin Meds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Kin Meds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Kin Meds shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Kin Meds names 2 pharmacies that fill its prescriptions, including Rush Pharmacy, which most sellers do not do.
Price shown before you start
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $249. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Kin Meds serves your state before you start.
- The FDA has issued Kin Meds a warning letter. It is covered in the enforcement section below; read what it alleges before you decide.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Kin Meds
- Phone
- (310) 923-9547
- Kin Meds offers email support
- Hours
- Mon-Fri 9:00am-5:00pm; Sat-Sun closed
Cancelling Kin Meds
Taken from the terms Kin Meds publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- None stated; 30- or 90-day supply, no auto-subscribe
- Refund policy
- Medication sales final once shipped; not charged for treatment if a provider declines
Medications Kin Meds lists
Kin Meds lists Wegovy, Zepbound, Foundayo, compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides Kin Meds offers
Kin Meds sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Personalized GLP-1, compounded semaglutide (from-price; buyer picks a 30- or 90-day supply)Compounded
$199/mo
semaglutide
Posted as 'Starting at $199' with shipping, supplies and the provider visit included. The page does not say whether $199 buys the 30-day or the 90-day supply.
Personalized GLP-1/GIP+B12, compounded tirzepatide (from-price; buyer picks a 30- or 90-day supply)Compounded
$249/mo
tirzepatide
Posted as 'Starting at $249' with shipping, supplies and the provider visit included.
Wegovy injection or pill: consultation fee only, medication billed separately by NovoCare PharmacyBrand-name
$149/mo
semaglutide
Kin Meds charges $149/mo for the consult. NovoCare Pharmacy fills the prescription and sets the medication price.
Zepbound pen or vial: consultation fee only, medication billed separately by LillyDirectBrand-name
$149/mo
tirzepatide
Kin Meds charges $149/mo for the consult. LillyDirect fills the prescription and sets the medication price.
Foundayo: consultation fee only, medication billed separately by LillyDirectBrand-name
$149/mo
orforglipron
Kin Meds charges $149/mo for the consult. LillyDirect fills the prescription and sets the medication price.
Check the price yourself before you pay
Every figure here comes from Kin Meds's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Kin Meds compounding-pharmacy partners
Kin Meds names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
Strive Pharmacy
“Prescriptions are filled by licensed U.S. partner pharmacies, including Rush Pharmacy and Strive Pharmacy, that meet federal and state requirements.”
In its favor
- Semaglutide costs $199 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $249 a month, 7% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Names 2 pharmacies that fill its prescriptions, which most sellers do not
Against it
- Confirm it serves your state before you start the intake
- The FDA has issued Kin Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Kin Meds charges
The standing price at Kin Meds is $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $249/month
- Consult fee (Wegovy billed separately): $149/month
- Consult fee (Zepbound billed separately): $149/month
- Consult fee (Foundayo billed separately): $149/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Kin Meds' $249 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare Kin Meds' cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Kin Meds dispenses
Kin Meds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The difference is not cosmetic. The approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy. Some of Kin Meds' preparations are mixed with B12; why compounders add it separates what is established from what is only claimed. Foundayo is the GLP-1 pill with no fasting rule, approved in April 2026.
Safety and disclosure
Kin Meds tells you its price before you start the medical questionnaire and the pharmacy that fills its prescriptions. The FDA has issued Kin Meds a warning letter, summarized at the top of this page. A letter flags a problem rather than ruling a seller out, so read what it says before deciding what it means for you. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. Across the market, the FDA's GLP-1 warning letters are mostly about what sellers said rather than what pharmacies made. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Kin Meds bills your plan before you start.
- A seller's regulatory history matters to you more than price. Read the warning letter summarized above before deciding.
Our read
Kin Meds lands mid-market on price. The catch is disclosure, which is why Kin Meds scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Belle Health is the nearest comparison we review, and worth reading alongside this. Whatever you decide, read the warning letter summarized at the top of this page first, and raise it with the clinician who would prescribe for you.
The Bottom Line
Kin Meds falls below our bar on oversight: the FDA has issued it a warning letter. It charges from $199 a month; its compounded tirzepatide, at $249, is 7% below the $269 median among the sellers we compare.
Score: 6.9/10Best for: oral orforglipron alongside the injectablesFrom: $199/mo
Before you pay Kin Meds
Starting at $199 a month. Check today's price, then start the intake.
Where Kin Meds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Kin Meds sets more sellers in the same category beside Kin Meds on price, states and what the price includes.
Frequently Asked Questions
Kin Meds sells compounded semaglutide from $199 and compounded tirzepatide from $249, covering shipping, supplies and the visit, and nothing renews on its own. It also prescribes Wegovy, Zepbound and Foundayo for a $149/mo consultation fee, with the medication billed on top by NovoCare or LillyDirect. The same account covers TRT, hormones, NAD+, sermorelin, skin and sexual health. We rate it 6.9/10 overall.
Kin Meds starts at $199 a month. The pricing table above lists every tier.
Ask Kin Meds whether it serves your state before you start the intake, and get the answer in writing.
Kin Meds lists Wegovy, Zepbound, Foundayo, compounded semaglutide and compounded tirzepatide. It lists both FDA-approved brand-name products and cheaper compounded versions.
Kin Meds lists both. Compounded semaglutide and tirzepatide come out of a licensed compounding pharmacy and cost less. The brand pens are the FDA-approved reference products and cost more. What you give up on each path is set out in the review above.
Check whether Kin Meds bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. Kin Meds runs that whole sequence on its own site.
The FDA warning letter is the one that matters, and it is summarized at the top of this review. Also weigh these before you buy: Confirm it serves your state before you start the intake. Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Other sellers we cover include Belle Health, HumeCare+, and Gala. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.
How to check Kin Meds yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Kin Meds has an FDA warning letter on record, dated February 20, 2026
This letter concerns false & misleading claims/misbranded. A warning letter is public correspondence from FDA, not an adjudication. On its own it establishes no finding of illegal activity, and a company that gets one often answers with corrective action.
Sources
Cited across this Kin Meds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Kin Meds's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on Kin Meds?
Vetted alternatives